Advertisement
Product › Details
AGE1.CR duck cell line
Next higher product group | rPP [recombinant protein production] | |
Status | 2007-05-31 development existent | |
Organisation | ProBioGen AG | |
Group | Minapharm (Group) | |
Record changed: 2023-07-10 |
Advertisement
More documents for AGE1.CR duck cell line
- [1] ProBioGen AG. (3/24/21). "Press Release: ProBioGen Enters into Agreement with Nobelpharma for Manufacturing Process Development of their Vaccine Project". Berlin....
- [2] ProBioGen AG. (10/1/19). "Press Release: ProBioGen and Ceva Santé Animale Sign an Exclusive License Agreement to Produce Vectorised Poultry Vaccines Using AGE1.CR Production Technology". Berlin....
- [3] ProBioGen AG. (5/15/19). "Press Release: ProBioGen and Vaccitech Sign License Agreement for ProBioGen’s Technology Platform". Berlin & Oxford....
- [4] ProBioGen AG. (6/26/18). "Press Release: ProBioGen and Nouscom Sign License Agreement for ProBioGen’s Technology Platform". Berlin & Basel....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top